Genome Editing Technology Market By Application (Animal Genetic Engineering, Cell Line Engineering, Plant Genetic), By Technology (Crisper, ZFN, TALEN, Antisense Technology), By End User (Contract Research Organizations, Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Apr 20, 2016

Key Findings


The global genome editing technology market is expected to grow at the CAGR of 14.1% during 2015-2022. The major factors driving the market are rising of genetically modified crop production, technological advancement, rise of biotechnology and pharmaceutical industry. Recent advancement in genome editing technology is CRISPR facilitating rapid and specific manipulations in gene sequence. Genetically modified crop production is highly adopted over conventional as it provides several benefits such as reduction of chemical pesticides and increase in yield. Although there are many factors driving the market yet there are some challenges faced by the market such as high capital investment and regulatory controls.


Market Segment Insight


The market is majorly segmented on the basis of application, technology, end user. On the basis of application the market is further segmented in to animal genetic engineering, plant genetic engineering, cell line engineering. Out of this cell engineering has largest share followed by plant genetic engineering. On the basis of end user the market is further segmented in contract research organization, academic and government research institutions and biotechnology and pharmaceutical companies. Amongst this biotechnology and pharmaceutical companies segment has the largest market share. Biotechnology and pharmaceutical has become the most important tool for drug research and development.


Regional Insight


Based on application the market is segmented into North America, Europe, APAC and RoW. North America has the largest market share globally and is followed by APAC, Europe and RoW. In 2014, US produced 92% of cotton, 94% of corn and 94% of soybean using genetic editing technology. Growing pharmaceutical and biotechnology industries in North America and Asia pacific largely is expected to affect the genome editing technology market.


Competitive Insights


Some of the major market players are Thermo Fisher Scientific Inc, Integrated DNA Technologies Inc, Origene Technologies Inc, Sangamo Biosciences, Lonza Group Ltd, Horizon Discovery Group Plc. Expansions, acquisitions and investment in R&D are key strategies used by the markets.

CHAP 1. METHODOLOGY & SCOPE 11
1.1. RESEARCH METHODOLOGY 11
1.2. RESEARCH SCOPE & ASSUMPTIONS 11
1.3. LIST OF DATA SOURCES 11


CHAP 2. EXECUTIVE SUMMARY 12
2.1. GLOBAL GENOME EDITING TECHNOLOGY MARKETSUMMARY & KEY BUYING CRITERIA 12
2.2. GLOBAL GENOME EDITING TECHNOLOGY MARKETOUTLOOK 12
2.3. MARKET SEGMENTATION ANALYSIS 12
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 12
2.5. GLOBAL GENOME EDITING TECHNOLOGY MARKETVALUE CHAIN ANALYSIS 12
2.6. VENDOR LANDSCAPE 12


CHAP 3. GLOBAL GENOME EDITING TECHNOLOGY MARKET 13
3.1. MARKET DRIVER ANALYSIS 13
3.1.1. GENETICALLY MODIFIED CROPS PRODUCTION RISING GLOBALLY 13
3.1.2. TECHNOLOGICAL ADVANCEMENTS 13
3.1.3. RISE OF BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES 13
3.2. MARKET RESTRAINT ANALYSIS 13
3.2.1. PUBLIC PERCEPTION ABOUT GENETIC RESEARCH 13
3.2.2. TIME CONSUMING APPROVAL PROCESS AND STRICT REGULATIONS 13
3.2.3. HEALTH RELATED ISSUES IN GENETICALLY MODIFIED PRODUCTS 13
3.3. KEY OPPORTUNITIES 13
3.3.1. RISING MARKET IN DEVELOPING COUNTRIES 13
3.3.2. RISING DEMAND OF PRODUCTS SUCH AS BIOPESTICIDES 13
3.4. CHALLENGES 13
3.4.1. LACK OF SKILLED WORKFORCE 13
3.4.2. HIGH CAPITAL INVESTMENTS 13


CHAP 4. INDUSTRY ANALYSIS 14
4.1. GLOBAL GENOME EDITING TECHNOLOGY MARKET– PORTER’S FIVE FORCE MODEL 14
4.2. GLOBAL GENOME EDITING TECHNOLOGY MARKET– PESTEL ANALYSIS 14
4.3. GLOBAL GENOME EDITING TECHNOLOGY MARKET– GAP ANALYSIS 14


CHAP 5. GLOBL GENOME EDITING TECHNOLOGY MARKET BY APPLICATION 2012-2022 ($ BILLION) 15
5.1. GLOBAL GENOME EDITING TECHNOLOGY MARKET BY ANIMAL GENETIC ENGINEERING, 2012-2022 ($ BILLION) 15
5.2. GLOBAL GENOME EDITING TECHNOLOGY MARKET BY CELL LINE ENGINEERING , 2012-2022 ($ BILLION) 15
5.3. GLOBAL GENOME EDITING TECHNOLOGY MARKET BY PLANT GENETIC, 2012-2022 ($ BILLION) 15
5.4. GLOBAL GENOME EDITING TECHNOLOGY MARKET BY OTHER, 2012-2022 ($ BILLION) 15


CHAP 6. GLOBAL GENOME EDITING TECHNOLOGY MARKET BY TECHNOLOGY 2012-2022 ($ BILLION) 16
6.1. GLOBAL GENOME EDITING TECHNOLOGY MARKET BY CRISPR, 2012-2022 ($ BILLION) 16
6.2. GLOBAL GENOME EDITING TECHNOLOGY MARKET BY ZFN, 2012-2022 ($ BILLION) 16
6.3. GLOBAL GENOME EDITING TECHNOLOGY MARKET BY TALEN, 2012-2022 ($ BILLION) 16
6.4. GLOBAL GENOME EDITING TECHNOLOGY MARKET BY ANTISENSE TECHNOLOGY , 2012-2022 ( $ BILLION) 16
6.5. GLOBAL GENOME EDITING TECHNOLOGY MARKET BY OTHERS , 2012-2022 ( $ BILLION) 16


CHAP 7. GLOBAL GENOME EDITING TECHNOLOGY MARKET BY END USER 2012-2022 ($ BILLION) 17
7.1. GLOBAL GENOME EDITING TECHNOLOGY MARKET BY CONTRACT RESEARCH ORGANIZATIONS , 2012-2022 ($ BILLION) 17
7.2. GLOBAL GENOME EDITING TECHNOLOGY MARKET BY ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, 2012-2022 ($ BILLION) 17
7.3. GLOBAL GENOME EDITING TECHNOLOGY MARKET BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2012-2022 ($ BILLION) 17


CHAP 8. GLOBAL GENOME EDITING TECHNOLOGY MARKET, REGIONAL OUTLOOK 2012-2022 ($ BILLION) 18
8.1. GLOBAL GENOME EDITING TECHNOLOGY MARKET BY REGION 2012-2022 ($ BILLION) 18
8.2. NORTH AMERICA 18
8.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 18
8.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 18
8.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 18
8.2.3.1. U.S. 18
8.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 18
8.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 18
8.2.3.2. CANADA 18
8.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 18
8.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 18
8.3. EUROPE 18
8.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 18
8.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 18
8.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 18
8.3.3.1. GERMANY 18
8.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
8.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
8.3.3.2. UK 19
8.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
8.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
8.3.3.3. FRANCE 19
8.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
8.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
8.3.3.4. REST OF EUROPE 19
8.3.3.4.1. OTHERS MARKET ESTIMATES AND FORECAST2012-2022($BILLION) 19
8.3.3.4.2. OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 19
8.4. ASIA PACIFIC 19
8.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
8.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 19
8.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
8.4.3.1. CHINA 19
8.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
8.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
8.4.3.2. INDIA 20
8.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
8.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
8.4.3.3. JAPAN 20
8.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
8.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION) 20
8.4.3.4. OTHERS 20
8.4.3.4.1. OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($BILLION) 20
8.4.3.4.2. OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 20
8.5. REST OF THE WORLD 20
8.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
8.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20


CHAP 9. COMPETITIVE LANDSCAPE 21
9.1. LONZA GROUP LTD 22
9.1.1. COMPANY OVERVIEW 22
9.1.2. SCOT ANALYSIS 22
9.1.3. PRODUCT BENCHMARKING 22
9.1.4. STRATEGIC INITIATIVES 22
9.2. INTEGRATED DNA TECHNOLOGIES,INC 22
9.2.1. COMPANY OVERVIEW 22
9.2.2. SCOT ANALYSIS 22
9.2.3. PRODUCT BENCHMARKING 22
9.2.4. STRATEGIC INITIATIVES 22
9.3. SANGAMO BIOSCIENCES INC 22
9.3.1. COMPANY OVERVIEW 22
9.3.2. SCOT ANALYSIS 22
9.3.3. PRODUCT BENCHMARKING 22
9.3.4. STRATEGIC INITIATIVES 22
9.4. GENSCRIPT USA INC 22
9.4.1. COMPANY OVERVIEW 22
9.4.2. SCOT ANALYSIS 22
9.4.3. PRODUCT BENCHMARKING 22
9.4.4. STRATEGIC INITIATIVES 22
9.5. SIGMA ALDRICH CORPORATION 22
9.5.1. COMPANY OVERVIEW 22
9.5.2. SCOT ANALYSIS 22
9.5.3. PRODUCT BENCHMARKING 22
9.5.4. STRATEGIC INITIATIVES 22
9.6. HORIZON DISCOVERY GROUP PLC 22
9.6.1. COMPANY OVERVIEW 22
9.6.2. SCOT ANALYSIS 23
9.6.3. PRODUCT BENCHMARKING 23
9.6.4. STRATEGIC INITIATIVES 23
9.7. THERMO FISHER SCIENTIFIC INC 23
9.7.1. COMPANY OVERVIEW 23
9.7.2. SCOT ANALYSIS 23
9.7.3. PRODUCT BENCHMARKING 23
9.7.4. STRATEGIC INITIATIVES 23
9.8. ORIGENE TECHNOLOGIES INC 23
9.8.1. COMPANY OVERVIEW 23
9.8.2. SCOT ANALYSIS 23
9.8.3. PRODUCT BENCHMARKING 23
9.8.4. STRATEGIC INITIATIVES 23
9.9. NEW ENGLAND BIOLABS, INC 23
9.9.1. COMPANY OVERVIEW 23
9.9.2. SCOT ANALYSIS 23
9.9.3. PRODUCT BENCHMARKING 23
9.9.4. STRATEGIC INITIATIVES 23
9.10. TRANSPOSAGEN BIOPHARMACEUTICAL INC 23
9.10.1. COMPANY OVERVIEW 23
9.10.2. SCOT ANALYSIS 23
9.10.3. PRODUCT BENCHMARKING 23
9.10.4. STRATEGIC INITIATIVES 23
9.11. INNOVATIVE GENOMICS INITIATIVE 23
9.11.1. COMPANY OVERVIEW 23
9.11.2. SCOT ANALYSIS 23
9.11.3. PRODUCT BENCHMARKING 23
9.11.4. STRATEGIC INITIATIVES 23
9.12. PRECISION BIOSCIENCES INC 24
9.12.1. COMPANY OVERVIEW 24
9.12.2. SCOT ANALYSIS 24
9.12.3. PRODUCT BENCHMARKING 24
9.12.4. STRATEGIC INITIATIVES 24
9.13. TOOLGEN INC 24
9.13.1. COMPANY OVERVIEW 24
9.13.2. SCOT ANALYSIS 24
9.13.3. PRODUCT BENCHMARKING 24
9.13.4. STRATEGIC INITIATIVES 24
9.14. NOVA SYNTHETIX 24
9.14.1. COMPANY OVERVIEW 24
9.14.2. SCOT ANALYSIS 24
9.14.3. PRODUCT BENCHMARKING 24
9.14.4. STRATEGIC INITIATIVES 24
9.15. SYSTEM BIOSCIENCES 24
9.15.1. COMPANY OVERVIEW 24
9.15.2. SCOT ANALYSIS 24
9.15.3. PRODUCT BENCHMARKING 24
9.15.4. STRATEGIC INITIATIVES 24

TABLE 1 GLOBL GENOME EDITING TECHNOLOGY MARKET BY APPLICATION 2012-2022 ($ BILLION) 24
TABLE 2 GLOBAL GENOME EDITING TECHNOLOGY MARKET BY ANIMAL GENETIC ENGINEERING, 2012-2022 ($ BILLION) 24
TABLE 3 GLOBAL GENOME EDITING TECHNOLOGY MARKET BY CELL LINE ENGINEERING , 2012-2022 ($ BILLION) 24
TABLE 4 GLOBAL GENOME EDITING TECHNOLOGY MARKET BY PLANT GENETIC, 2012-2022 ($ BILLION) 25
TABLE 5 GLOBAL GENOME EDITING TECHNOLOGY MARKET BY OTHER, 2012-2022 ($ BILLION) 25
TABLE 6 GLOBAL GENOME EDITING TECHNOLOGY MARKET BY TECHNOLOGY 2012-2022 ($ BILLION) 25
TABLE 7 GLOBAL GENOME EDITING TECHNOLOGY MARKET BY CRISPR, 2012-2022 ($ BILLION) 25
TABLE 8 GLOBAL GENOME EDITING TECHNOLOGY MARKET BY ZFN, 2012-2022 ($ BILLION) 25
TABLE 9 GLOBAL GENOME EDITING TECHNOLOGY MARKET BY TALEN, 2012-2022 ($ BILLION) 25
TABLE 10 GLOBAL GENOME EDITING TECHNOLOGY MARKET BY ANTISENSE TECHNOLOGY , 2012-2022 ( $ BILLION) 25
TABLE 11 GLOBAL GENOME EDITING TECHNOLOGY MARKET BY OTHERS , 2012-2022 ( $ BILLION) 25
TABLE 12 GLOBAL GENOME EDITING TECHNOLOGY MARKET BY END USER 2012-2022 ($ BILLION) 25
TABLE 13 GLOBAL GENOME EDITING TECHNOLOGY MARKET BY CONTRACT RESEARCH ORGANIZATIONS , 2012-2022 ($ BILLION) 25
TABLE 14 GLOBAL GENOME EDITING TECHNOLOGY MARKET BY ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, 2012-2022 ($ BILLION) 25
TABLE 15 GLOBAL GENOME EDITING TECHNOLOGY MARKET BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2012-2022 ($ BILLION) 25
TABLE 16 NORTH AMERICA GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 25
TABLE 17 NORTH AMERICA GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 25
TABLE 18 NORTH AMERICA GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 25
TABLE 19 U.S. GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 26
TABLE 20 U.S. GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 26
TABLE 21 CANADA GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 26
TABLE 22 CANADA GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 –2022 ($ BILLION) 26
TABLE 23 CANADA GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 26
TABLE 24 EUROPE GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 26
TABLE 25 EUROPE GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 26
TABLE 26 EUROPE GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 26
TABLE 27 GERMANY GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 26
TABLE 28 GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 26
TABLE 29 UK GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 26
TABLE 30 UK GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 26
TABLE 31 ASIA PACIFIC GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 26
TABLE 32 ASIA PACIFIC GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 27
TABLE 33 ASIA PACIFIC GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 27
TABLE 34 CHINA GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 27
TABLE 35 CHINA GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 27
TABLE 36 INDIA GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 27
TABLE 37 INDIA GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 27
TABLE 38 JAPAN GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 27
TABLE 39 JAPAN GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 27
TABLE 40 MIDDLE EAST & AFRICA GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 27
TABLE 41 MIDDLE EAST & AFRICA GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 27
TABLE 42 CENTRAL & SOUTH AMERICA GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 27
TABLE 43 CENTRAL & SOUTH AMERICA GLOBAL GENOME EDITING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 27

FIGURE 1 MARKET SHARE BY REGIONS 28
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 8 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 9 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 10 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 11 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 12 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 13 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)